Legal Representation
Attorney
Jessica L. Rothstein
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 6, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 13, 2023 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Feb 28, 2023 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Feb 11, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 9, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 9, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 9, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 9, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 9, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Nov 16, 2022 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Oct 21, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 21, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 21, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 12, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 12, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 12, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 12, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 4, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 3, 2021 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 2, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 18, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Business consulting and management in the field of clinical trials, namely, providing information management services; formulation of best practices for clinical trial execution and management for the testing of drugs, biologics, and medical devices; preparation of business reports related to key trends and innovations in clinical trial execution and management for the testing of drugs, biologics, and medical devices; conducting conferences in the fields of clinical trials for the testing of drugs, biologics, and medical devices for business purposes; association services, namely, promoting the interests of the clinical trial field
First Use Anywhere:
Jun 2, 2021
First Use in Commerce:
Jun 2, 2021
Class 041
Conducting seminars in the fields of clinical trials for the testing of drugs, biologics, and medical devices; conducting educational programs, presentations, conferences and seminars in the fields of clinical trials for the testing of drugs, biologics, and medical devices; Educational services, namely, providing on-line business training, courses and seminars in the field of clinical trials for the testing of drugs, biologics, and medical devices
First Use Anywhere:
Jun 2, 2021
First Use in Commerce:
Jun 2, 2021
Class 042
Technical consulting in the field of clinical trials for the testing of drugs, biologics, and medical devices; consulting services in the fields of research and development for drugs, biologics, and medical devices
First Use Anywhere:
Jun 2, 2021
First Use in Commerce:
Jun 2, 2021
Additional Information
Design Mark
The mark consists of the letters "WCG" in bold font and "AVOCA" in larger font. Above the "G" and the "A" is a design of five linking shaded hexagons in the shape of a right-facing arrow.
Pseudo Mark
WIRB COPERNICUS GROUP AVOCA
Classification
International Classes
035
041
042